Olanzapine (10 mg vs 5 mg vs 2.5 mg) for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) - a systematic review and network meta-analysis.
Saved in:
| Title: | Olanzapine (10 mg vs 5 mg vs 2.5 mg) for the prophylaxis of chemotherapy-induced nausea and vomiting (CINV) - a systematic review and network meta-analysis. |
|---|---|
| Authors: | Chow R; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada. ronald.chow@sunnybrook.ca.; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. ronald.chow@sunnybrook.ca.; Centre for Evidence-Based Medicine, University of Oxford, Oxford, UK. ronald.chow@sunnybrook.ca.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada. ronald.chow@sunnybrook.ca., Zhang D; Siebel School of Computing and Data Science, University of Illinois Urbana-Champaign, Champaign, IL, USA., Chai GW; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Yuen M; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Lu A; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Fortuna V; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Talwar S; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada., Boldt G; Siebel School of Computing and Data Science, University of Illinois Urbana-Champaign, Champaign, IL, USA.; Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada., Lock M; Siebel School of Computing and Data Science, University of Illinois Urbana-Champaign, Champaign, IL, USA.; Schulich School of Medicine & Dentistry, University of Western Ontario, London, ON, Canada., Lee SF; Department of Radiation Oncology, National University Cancer Institute, National University Hospital, Singapore, Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Eng L; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Princess Margaret Cancer Centre, University Health Network, Toronto, ON, Canada., Iihara H; Department of Pharmacy, Gifu University Hospital, 1-1 Yanagido, Gifu, Gifu, 501-1194, Japan.; Cancer Center, Gifu University Hospital, 1-1 Yanagido, Gifu, Gifu, 501-1194, Japan., Affronti ML; Duke University School of Nursing, Duke University, Durham, NC, USA., Saito M; Juntendo University Graduate School of Medicine, Bunkyo-Ku, Tokyo, 113-8421, Japan., Aapro M; Genolier Cancer Centre, Geneva, Switzerland., Hesketh PJ; Lahey Cancer Institute, Lahey Hospital & Medical Centre, Burlington, MA, USA., Scotté F; Département Interdisciplinaire D'Organisation Des Parcours Patients, Gustave-Roussy, Université Paris-Saclay, 94800, Villejuif, France., Ruhlmann CH; Department of Oncology, Odense University Hospital, Odense, Denmark., Leigh J; Temerty Faculty of Medicine, University of Toronto, Toronto, ON, Canada.; Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, ON, Canada. |
| Corporate Authors: | MASCC Antiemetic Study Group |
| Source: | Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer [Support Care Cancer] 2026 Jul 16; Vol. 34 (8). Date of Electronic Publication: 2026 Jul 16. |
| Publication Type: | Journal Article; Systematic Review; Network Meta-Analysis; Review |
| Journal Info: | Publisher: Springer International Country of Publication: Germany NLM ID: 9302957 Publication Model: Electronic Cited Medium: Internet ISSN: 1433-7339 (Electronic) Linking ISSN: 09414355 NLM ISO Abbreviation: Support Care Cancer Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
